TrialThe Lancet. Oncology2025

Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.

Berend J van der Wilk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.